secwatch.observer — SEC 8-K summary
======================================

Issuer:     Black Diamond Therapeutics, Inc. (BDTX)
CIK:        0001701541
Form:       8-K
Filed at:   2026-06-29T20:20:51+00:00
Accession:  0001104659-26-078847
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

BDTX annual meeting elects directors; Kapil Dhingra elected despite majority withheld votes
--------------------------------------------------------------------------------

- Shannon Campbell elected as Class III director with 19.3M for, 17.2M withheld; Kapil Dhingra elected with 14.0M for, 22.5M withheld.
- Ratification of PwC as auditor approved: 44.4M for, 0.1M against, 0.2M abstain.
- Advisory vote on executive compensation passed: 35.1M for, 1.2M against, 0.2M abstain, 8.2M broker non-votes.
- Frequency of future say-on-pay set to annual (30.4M for 1-year); company will hold annual advisory votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1701541/000110465926078847/0001104659-26-078847-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1701541/000110465926078847/tm2619324d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-078847

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer